Related Experiment Video
Updated: Oct 19, 2025

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Stability of Symptom Clusters in Patients With Gynecologic Cancer Receiving Chemotherapy
Rachel A Pozzar1, Marilyn J Hammer, Bruce A Cooper
1Author Affiliations: Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute (Drs Pozzar and Hammer), Boston, Massachusetts; School of Nursing (Drs Cooper, Kober, Paul, and Miaskowski) and School of Medicine, University of California, San Francisco (Drs Chen, Levine, and Miaskowski); School of Nursing, University of Pittsburgh (Dr Conley), Pennsylvania; Mount Sinai Medical Center (Dr Cartwright), New York, New York; and Rory Myers College of Nursing, New York University (Dr Wright), New York.
Background:
Patients with gynecologic cancer undergoing chemotherapy experience multiple co-occurring symptoms. Understanding how symptom clusters change over time is essential to the development of interventions that target multiple co-occurring symptoms.
Objective:
The aim of this study was to assess the relative stability of symptom clusters across a chemotherapy cycle in patients with gynecologic cancer.
Methods:
This is a longitudinal, descriptive study. Eligible patients (n = 232) were English-speaking adults (≥18 years old) with gynecologic cancer. Data were collected in the week before patients' second or third cycle of chemotherapy (T1) and at 1 (T2) and 2 (T3) weeks after chemotherapy. Three dimensions of the symptom experience (occurrence, severity, and distress) were assessed using a modified version of the Memorial Symptom Assessment Scale. Symptom clusters for each dimension and time point were identified through exploratory factor analysis.
Results:
A 5-factor solution was selected for each exploratory factor analysis. Hormonal, respiratory, and weight change clusters were identified across all dimensions and time points. A psychological symptom cluster was identified at T1 for occurrence and severity and at T2 and T3 for all 3 dimensions. A gastrointestinal symptom cluster was identified at T1 for occurrence and at T2 and T3 for all 3 dimensions. The hormonal, respiratory, psychological, and weight change symptom clusters exhibited common symptoms across dimensions and time points.
Conclusions:
Hormonal, respiratory, weight change, and psychological symptom clusters are relatively stable across a cycle of chemotherapy in patients with gynecologic cancer.
Implications For Practice:
Clinicians need to assess patients for multiple co-occurring symptoms and initiate multimodal interventions.
More Related Videos
Related Concept Videos
Disorders of the Female Reproductive System
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Cancer Survival Analysis

